Therefore, elevated leptin levels could increase the risk of the subsequent development of obesity-related non-communicable diseases such as CVD, type 2 diabetes, metabolic syndrome (MetS), and even some types of cancer [8,12,47,48]. This evidence concerns the gene LEP and type 2 diabetes mellitus.